Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer
- Sponsor
- Universidad Europea de Madrid
- Study ID
- NCT07470268
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- supervised, hypertrophy-oriented strength training program — OTHER12-week supervised, hypertrophy-oriented strength training program in preserving skeletal muscle mass
Study Details
To determine the efficacy of a 12-week supervised, hypertrophy-oriented strength training program in preserving skeletal muscle mass, physical function, and quality of life in patients with unresectable pancreatic cancer compared to standard care.
Key Dates
- First listed
- Mar 13, 2026
- Start date
- Sep 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Sep 1, 2027
- Completion
- Sep 1, 2027
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Intervention Group12 weeks of hypertrophy training in patients with advanced, unresectable PC receiving chemotherapy and/or immunotherapy
- No Intervention: Control GroupParticipants in the control group will receive standard oncological treatment. No restrictions on physical activity will be imposed. Furthermore, they will be offered the opportunity to follow the exercise program used in the intervention group if the expected benefits proposed in the study hypothesis are confirmed.
Primary Outcome Measure
Body Composition [ Time Frame: Through study completion, an average of 1 year ]
Find similar trials
Related Studies
- Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruiting · Mayo Clinic · Phoenix, Arizona
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Pancreatic Adenocarcinoma Gene Environment Risk StudyRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic DiseaseRecruiting · Columbia University · New York, New York